文献速递胰腺与胆道疾病消化道肿瘤与早癌消化内镜

无覆膜与全覆膜自膨式金属支架治疗远端恶性胆道梗阻的比较

Uncovered versus fully covered self-expandable metal stents for the management of distal malignant biliary obstruction.
PubMed 文献 · Gastrointest Endosc · 2023-05-16

这项回顾性队列研究纳入2017年5月至2021年5月间接受支架置入的454例远端恶性胆道梗阻患者,比较无覆膜与全覆膜自膨式金属支架的临床结局。两组临床成功率相当,但无覆膜支架的不良事件率、非计划内镜再干预率和支架闭塞率更高,支架闭塞时间更短;全覆膜支架的支架移位率更高。作者认为全覆膜支架因不良事件少、通畅时间长、非计划内镜干预少,应考虑用于远端恶性胆道梗阻的姑息治疗。

要点

  • 无覆膜支架组不良事件率33.5% vs 全覆膜支架组21.1%(P = .023)。
  • 无覆膜支架组非计划内镜再干预率27.0% vs 全覆膜支架组11.1%(P = .002)。
  • 无覆膜支架闭塞后置入同轴塑料支架的再闭塞率46.7% vs 同轴金属支架19.7%(P = .007)。

核心结论

  • 作者认为,全覆膜自膨式金属支架因不良事件率更低、通畅时间更长、非计划内镜干预率更低,应考虑用于远端恶性胆道梗阻的姑息治疗。

研究设计与样本

  • 回顾性队列研究,纳入2017年5月至2021年5月间接受无覆膜或全覆膜自膨式金属支架置入的远端恶性胆道梗阻患者454例,其中无覆膜支架组364例、全覆膜支架组90例。
  • 中位随访时间9.6个月,两组相似。

主要发现

  • 两组临床成功率相当(P = .250)。
  • 无覆膜支架组不良事件率33.5% vs 全覆膜支架组21.1%(P = .023),非计划内镜再干预率27.0% vs 11.1%(P = .002)。
  • 无覆膜支架组支架闭塞率26.9% vs 全覆膜支架组8.9%(P < .001),中位支架闭塞时间4.4个月 vs 10.7个月(P = .002);全覆膜支架组无支架再干预生存率更高。
  • 全覆膜支架组支架移位率7.8% vs 无覆膜支架组1.1%(P < .001);两组胆囊炎发生率.3% vs 1.1%(P = .872)、内镜逆行胰胆管造影术后胰腺炎发生率6.3% vs 6.6%(P = .90)相似。
  • 无覆膜支架闭塞后,置入同轴塑料支架的再闭塞率46.7% vs 置入同轴金属支架19.7%(P = .007)。

临床怎么用

  • 作者认为,全覆膜自膨式金属支架应考虑用于远端恶性胆道梗阻的姑息治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: Self-expandable metal stents (SEMSs) are widely used for palliation of distal malignant biliary obstruction (dMBO). However, previous studies comparing the outcomes between uncovered SEMSs (UCSEMSs) and fully covered SEMSs (FCSEMSs) report conflicting results. This large cohort study aimed to compare the clinical outcomes between UCSEMSs and FCSEMSs for dMBO. METHODS: A retrospective cohort study was performed in patients with dMBO who underwent either UCSEMS or FCSEMS placement between May 2017 and May 2021. Primary outcomes were rates of clinical success, adverse events (AEs), and unplanned endoscopic reintervention. Secondary outcomes were types of AEs, intervention-free stent patency, and management and outcomes of stent occlusion. RESULTS: The cohort included 454 patients (364 in the UCSEMS group and 90 in the FCSEMS group). Median follow-up duration was 9.6 months and was similar between the 2 groups. Use of UCSEMSs and FCSEMSs had comparable clinical success (P = .250). However, use of UCSEMSs had significantly higher rates of AEs (33.5% vs 21.1%; P = .023) and unplanned endoscopic reintervention (27.0% vs 11.1%; P = .002). UCSEMSs had a higher rate of stent occlusion (26.9% vs 8.9%; P < .001) and shorter median time to stent occlusion (4.4 months vs 10.7 months; P = .002). Stent reintervention-free survival was higher in the FCSEMS group. FCSEMSs had a significantly higher rate of stent migration (7.8% vs 1.1%; P < .001), but patients in the FCSEMS group had similar rates of cholecystitis (.3% vs 1.1%; P = .872) and post-ERCP pancreatitis (6.3% vs 6.6%; P = .90). When UCSEMSs did occlude, placement of a coaxial plastic stent had a higher rate of stent reocclusion compared with coaxial SEMS placement (46.7% vs 19.7%; P = .007). CONCLUSION: FCSEMSs should be considered for the palliation of dMBO because of lower rates of AEs, longer patency rates, and lower rates of unplanned endoscopic intervention.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ghazi R, AbiMansour JP, Mahmoud T, et al. Uncovered versus fully covered self-expandable metal stents for the management of distal malignant biliary obstruction. Gastrointest Endosc. 2023. PMID: 37201725. doi:10.1016/j.gie.2023.05.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。